Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Duke Energy
DUK
|
+$67.5M |
| 2 |
Alliant Energy
LNT
|
+$42.1M |
| 3 |
APA Corp
APA
|
+$40.9M |
| 4 |
DTE Energy
DTE
|
+$39.4M |
| 5 |
Apple
AAPL
|
+$39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$79.2M |
| 2 |
EOG Resources
EOG
|
+$69.3M |
| 3 |
Hubbell
HUBB
|
+$48.9M |
| 4 |
Nexstar Media Group
NXST
|
+$41.9M |
| 5 |
HF Sinclair
DINO
|
+$41.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.12% |
| 2 | Technology | 12.53% |
| 3 | Utilities | 11.68% |
| 4 | Healthcare | 10.47% |
| 5 | Energy | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
PubMatic
PUBM
$768M
| $133K | ﹤0.01% |
+10,414
| New | +$163K |
|
|
ARI
1502
Apollo Commercial Real Estate
ARI
$883M
| $131K | ﹤0.01% |
12,213
-129,990
| -91% | -$1.42M |
|
1503
Alight
ALIT
$408M
| $129K | ﹤0.01% |
+771
| New | +$129K |
|
|
DVAX
1504
DELISTED
Dynavax Technologies
DVAX
| $129K | ﹤0.01% |
+12,100
| New | +$141K |
|
1505
Equinox Gold
EQX
$15.9B
| $124K | ﹤0.01% |
+37,777
| New | +$130K |
|
1506
Globalstar
GSAT
$10.7B
| $123K | ﹤0.01% |
+6,180
| New | +$162K |
|
|
SYRS
1507
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $123K | ﹤0.01% |
+34,165
| New | +$148K |
|
1508
Vertical Aerospace
EVTL
$135M
| $121K | ﹤0.01% |
+3,562
| New | +$189K |
|
1509
StoneCo
STNE
$2.24B
| $118K | ﹤0.01% |
12,538
-74,125
| -86% | -$776K |
|
1510
NeoGenomics
NEO
$2.14B
| $117K | ﹤0.01% |
12,691
-17,036
| -57% | -$159K |
|
|
NGD
1511
DELISTED
New Gold Inc
NGD
| $113K | ﹤0.01% |
+114,912
| New | +$116K |
|
1512
Energy Fuels
UUUU
$3.71B
| $110K | ﹤0.01% |
+17,687
| New | +$117K |
|
1513
Precision BioSciences
DTIL
$239M
| $109K | ﹤0.01% |
+3,047
| New | +$120K |
|
|
LBRDA
1514
DELISTED
Liberty Broadband Class A
LBRDA
| $104K | ﹤0.01% |
1,369
-76
| -5% | -$6.18K |
|
1515
Pacific Biosciences
PACB
$395M
| $102K | ﹤0.01% |
+12,413
| New | +$107K |
|
|
CGC
1516
Canopy Growth
CGC
$472M
| $101K | ﹤0.01% |
+4,370
| New | +$135K |
|
1517
Praxis Precision Medicines
PRAX
$10.3B
| $101K | ﹤0.01% |
2,824
-1,457
| -34% | -$45.4K |
|
1518
Wipro
WIT
$18.9B
| $100K | ﹤0.01% |
42,936
-89,548
| -68% | -$214K |
|
|
VXRT
1519
DELISTED
Vaxart
VXRT
| $99K | ﹤0.01% |
103,363
-315,300
| -75% | -$446K |
|
|
ACCD
1520
DELISTED
Accolade Inc
ACCD
| $98K | ﹤0.01% |
+12,615
| New | +$120K |
|
|
WW
1521
DELISTED
WW International
WW
| $97K | ﹤0.01% |
25,225
-1,468
| -5% | -$5.88K |
|
1522
GCM Grosvenor
GCMG
$839M
| $96K | ﹤0.01% |
12,630
-85,069
| -87% | -$695K |
|
|
NVTA
1523
DELISTED
Invitae Corporation
NVTA
| $96K | ﹤0.01% |
51,738
-57,333
| -53% | -$140K |
|
|
HUYA
1524
Huya Inc
HUYA
$491M
| $94K | ﹤0.01% |
+23,879
| New | +$60.5K |
|
|
BCEL
1525
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $89K | ﹤0.01% |
+111,770
| New | +$142K |
|
Similar funds
Michael Gelband's Q4 2022 Portfolio in Review
As of Q4 2022, Michael Gelband held 2,335 positions worth $6.89B, down 9.9% from $7.65B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Michael Gelband withdrew a net $1.22B in Q4 2022, closing 751 positions and reducing 598 holdings. Its most notable exit was Nexstar Media Group, an estimated $41.9M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 14% a quarter earlier, followed by Technology and Utilities.
Against the trend, Michael Gelband opened a new position in Duke Energy worth $72.5M.
- Michael Gelband's largest Q4 2022 buy was Duke Energy: 703,463 shares worth $72.5M.
- Michael Gelband added most to Alliant Energy in Q4 2022, an estimated $42.1M increase.
- Michael Gelband's biggest Q4 2022 reduction was Exelon, cutting an estimated $79.2M.
- Michael Gelband fully exited Nexstar Media Group in Q4 2022, selling an estimated $41.9M.
- Michael Gelband's ten largest holdings make up 11% of its $6.89B portfolio in Q4 2022.
- Michael Gelband opened 504 new positions and closed 751 in Q4 2022.
- Michael Gelband's portfolio value fell 9.9% quarter-over-quarter to $6.89B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.